Skip to main content
. 2023 Jan 24;38(1):2166036. doi: 10.1080/14756366.2023.2166036

Figure 3.

Figure 3.

The fundamental structural requirements for SOR and rational of design of the novel postulated VEGFR-2 inhibitors.